Testimonials
Hear what our previous attendees have to say about The Inflammasome Therapeutics Summit
"Great meeting, very relevant content, many excellent speakers and outstanding networking. A very good start of creating a Inflammasome/NLRP3 focus group/community."
AstraZeneca
"Excellent, focused meeting with great mix of academic, clinical and industrial participation, facilitating great networking opportunities and interesting discussion."
Genentech
"Very good talks on many aspects of inflammasome biology and drug discovery, together with good networking opportunities, has triggered some new project ideas"
Vir Biotechnology
"The topics selected were great and covered the most relevant fields and interest around Inflammasome. A really focused, in-depth knowledge sharing experience."
Merck
